Transdermal agomelatine microemulsion gel: pyramidal screening, statistical optimization and in vivo bioavailability

References

• Abdelrahman FE, Elsayed I, Gad MK, et al. (2015). Investigating the cubosomal ability for transnasal brain targeting: in vitro optimization, ex vivo permeation and in vivo biodistribution. Int J Pharm 490:281–91.
   PubMed Web of Science ®Google Scholar
• Andrews G, Poulton R, Skoog I. (2005). Lifetime risk of depression: restricted to a minority or waiting for most? Br J Psychiatry 187:495–6.
   PubMed Web of Science ®Google Scholar
• Anurag J, Bhatia MS, Shruti S, Pankaj K. (2010). Agomelatine: a new antidepressant with a novel mechanism of action. Delhi Psychiatry J 13:170–8.
   Google Scholar
• Azeem A, Khan ZI, Aqil M, et al. (2009a). Microemulsions as a surrogate carrier for dermal drug delivery. Drug Dev Ind Pharm 35:525–47.
   PubMed Web of Science ®Google Scholar
• Azeem A, Rizwan M, Ahmad FJ, et al. (2009b). Nanoemulsion components screening and selection: a technical note. AAPS PharmSciTech 10:69–76.
   PubMed Web of Science ®Google Scholar
• Balaguer-Fernandez C, Femenia-Font A, Muedra V, et al. (2010). Combined strategies for enhancing the transdermal absorption of midazolam through human skin. J Pharm Pharmacol 62:1096–102.
   PubMed Web of Science ®Google Scholar
• Ban T. (2001). Pharmacotherapy of depression: a historical analysis. J Neural Transm (Vienna) 108:707–16.
   PubMed Web of Science ®Google Scholar
• Barot BS, Parejiya PB, Patel HK, et al. (2012). Microemulsion gel of terbinane for the treatment of onychomycosis: optimization of based formulation using D-optimal design. AAPS PharmSciTech 13:184–92.
   PubMed Web of Science ®Google Scholar
• Barton RR. 2013. Response surface methodology. In: Gass SI, Fu MC, eds. Encyclopedia of operations research and management science. Boston (MA): Springer, 1307–13.
   Google Scholar
• Basalious E, Shawky N, Badr-Eldin SM. (2010). SNEDDS containing bioenhancers for improvement of dissolution and oral absorption of lacidipine I: development and optimization. Int J Pharm 391:203–11.
   PubMed Web of Science ®Google Scholar
• Biruss B, Dietl R, Valenta C. (2007). The influence of selected steroid hormones on the physicochemical behaviour of DPPC liposomes. Chem Phys Lipids 148:84–90.
   PubMed Web of Science ®Google Scholar
• Chen H, Chang X, Weng T, et al. (2004). A study of microemulsion systems for transdermal delivery of triptolide. J Control Release 98:427–36.
   PubMed Web of Science ®Google Scholar
• Choi K, Hong T, Lee J. (2014). On comparison of SAS codes with GLM and MIXED for the crossover studies with QT interval data. Transl Clin Pharmacol 22:78–82.
   Google Scholar
• Constantinides PP. (1995). Lipid microemulsions for improving drug dissolution and oral absorption: physical and biopharmaceutical aspects. Pharm Res 12:1561–72.
   PubMed Web of Science ®Google Scholar
• Date AA, Nagarsenker MS. (2008). Design and evaluation of microemulsions for improved parenteral delivery of propofol. AAPS PharmSciTech 9:138–45.
   PubMed Web of Science ®Google Scholar
• Dehghani F, Farhadian N, Golmohammadzadeh S, et al. (2017). Preparation, characterization and in-vivo evaluation of microemulsions containing tamoxifen citrate anti-cancer drug. Eur J Pharm Sci 96:479–89.
   PubMed Web of Science ®Google Scholar
• Dempster EL, Wong CC, Lester KJ, et al. (2014). Genome-wide methylomic analysis of monozygotic twins discordant for adolescent depression. Biol Psychiatry 76:977–83.
   PubMed Web of Science ®Google Scholar
• Du T, Rao S, Wu L, et al. (2015). An association study of the m6A genes with major depressive disorder in Chinese Han population. J Affect Disord 183:279–86.
   PubMed Web of Science ®Google Scholar
• Du W, Zhou Y, Gong Y, Zhao C. (2013). Investigation of physicochemical properties and in-vitro in-vivo evaluation of agomelatine polymorphs. Asian J Pharm Sci 8:181–90.
   Google Scholar
• Elbary AA, Aboelwafa AA, Al Sharabi IM. (2011). Once daily, high-dose mesalazine controlled-release tablet for colonic delivery: optimization of formulation variables using Box–Behnken design. AAPS PharmSciTech 12:1454–64.
   PubMed Web of Science ®Google Scholar
• Elshafeey AH, Kamel AO, Fathallah MM. (2009). Utility of nanosized microemulsion for transdermal delivery of tolterodine tartrate: ex-vivo permeation and in-vivo pharmacokinetic studies. Pharm Res 26:2446–53.
   PubMed Web of Science ®Google Scholar
• Essa EA, Bonner MC, Barry BW. (2004). Electrically assisted skin delivery of liposomal estradiol; phospholipid as damage retardant. J Control Release 95:535–46.
   PubMed Web of Science ®Google Scholar
• Georgeta C, Viceniu V, Ioana O, et al. (2015). Development and evaluation of new microemulsion based hydrogel formulations for topical delivery of fluconazole. AAPS PharmSciTech 16:889–904.
   Google Scholar
• Hua L, Weisan P, Jiayu L, Ying Z. (2004). Preparation, evaluation, and NMR characterization of vinpocetine microemulsion for transdermal delivery. Drug Dev Ind Pharm 30:657–66.
   PubMed Web of Science ®Google Scholar
• Huang YB, Tsai YH, Yang WC, et al. (2004). Once-daily propranolol extended-release tablet dosage form: formulation design and in vitro/in vivo investigation. Eur J Pharm Biopharm 58:607–14.
   PubMed Web of Science ®Google Scholar
• Kennedy SH, Emsley R. (2006). Placebo-controlled trial of agomelatine in the treatment of major depressive disorder. Eur Neuropsychopharmacol 16:93–100.
   PubMed Web of Science ®Google Scholar
• Khurana S, Jain NK, Bedi PM. (2013). Nanoemulsion based gel for transdermal delivery of meloxicam: physico-chemical, mechanistic investigation. Life Sci 92:383–92.
   PubMed Web of Science ®Google Scholar
• Lawrence MJ, Rees GD. (2012). Microemulsion based media as novel drug delivery systems. Adv Drug Deliv Rev 64:175–93.
   Web of Science ®Google Scholar
• Lee PJ, Langer R. (2003). Novel microemulsion enhancer formulation for simultaneous transdermal delivery of hydrophilic and hydrophobic drugs. Pharm Res 20:264–9.
   PubMed Web of Science ®Google Scholar
• Lehmann L, Keipert S, Gloor M. (2001). Effects of microemulsions on the stratum corneum and hydrocortisone penetration. Eur J Pharm Biopharm 52:129–36.
   PubMed Web of Science ®Google Scholar
• Liu W, Hu M, Xue C, et al. (2008). Investigation of the carbopol gel of solid lipid nanoparticles for the transdermal ontophoretic delivery of triamcinolone acetonide acetate. Int J Pharm 264:135–41.
   Web of Science ®Google Scholar
• Liu Y, Chen L, Ji Y. (2013). Quantification and structural elucidation of potential impurities in agomelatine active pharmaceutical ingredient. J Pharm Biomed Anal 81–82:193–201.
   PubMed Web of Science ®Google Scholar
• Loo H, Hale A, D’haenen H. (2002). Determination of the dose of agomelatine, a melatoninergic agonist and selective 5-HT2C antagonist, in the treatment of major depressive disorder: a placebo-controlled dose range study. Int Clin Psychopharmacol 17:239–47.
   PubMed Web of Science ®Google Scholar
• Magnusson BM, Koskinen LD. (2000). In vitro percutaneous penetration of topically applied capsaicin in relation to in vivo sensation responses. Int J Pharm 195:55–62.
   PubMed Web of Science ®Google Scholar
• Mcneill SC, Potts RO, Francoeur ML. (1992). Local enhanced topical delivery (LETD) of drugs: does it truly exist? Pharm Res 9:1422–7.
   PubMed Web of Science ®Google Scholar
• Millan MJ, Gobert A, Lejeune F, et al. (2003). The novel melatonin agonist agomelatine (S20098) is an antagonistat 5-hydroxytryptamine 2C receptors, blockade of which enhances the activity of frontocortical dopaminergic and adrenergic pathways. J Pharmacol Exp Ther 306:954–64.
   PubMed Web of Science ®Google Scholar
• Montgomery SA. (2006). Major depressive disorders: clinical efficacy and tolerability of agomelatine, a new melatonergic agonist. Eur Neuropsychopharmacol 16:S633–S8.
   Web of Science ®Google Scholar
• Morsi NM, Abdelbary GA, Ahmed MA. (2014). Silver sulfadiazine based cubosome hydrogels for topical treatment of burns: development and in vitro/in vivo characterization. Eur J Pharm Biopharm 86:178–89.
   PubMed Web of Science ®Google Scholar
• Nair A, Vyas H, Shah J, Kumar A. (2011). Effect of permeation enhancers on the iontophoretic transport of metoprolol tartrate and the drug retention in skin. Drug Deliv 18:19–25.
   PubMed Web of Science ®Google Scholar
• Nicoli S, Santi P, Couvreur P, et al. (2001). Design of triptorelin loaded nanospheres for transdermal iontophoretic administration. Int J Pharm 214:31–5.
   PubMed Web of Science ®Google Scholar
• Paolino D, Ventura CA, Nistico S, et al. (2002). Lecithin microemulsions for the topical administration of ketoprofen: percutaneous adsorption through human skin and in vivo human skin tolerability. Int J Pharm 244:21–31.
   PubMed Web of Science ®Google Scholar
• Peltola S, Saarinen-Savolainen P, Kiesvaara J, et al. (2003). Microemulsions for topical delivery of estradiol. Int J Pharm 254:99–107.
   PubMed Web of Science ®Google Scholar
• Preskorn SH. (1997). Clinically relevant pharmacology of selective serotonin reuptake inhibitors. Clin Pharmacokinet 32:1–21.
   PubMed Web of Science ®Google Scholar
• Raza K, Singh B, Singal P, et al. (2013b). Systematically optimized biocompatible isptretinoin-loaded solid lipid nanoparticles (SLNs) for topical treatment of acne. Colloids Surf B 105:67–74.
   PubMed Web of Science ®Google Scholar
• Reagan-Shaw S, Nihal M, Ahmad N. (2008). Dose translation from animal to human studies revisited. FASEB J 22:659–61.
   PubMed Web of Science ®Google Scholar
• Rouillon F. (2006). Efficacy and tolerance profile of agomelatine and practical use in depressed patients. Int Clin Psychopharmacol 21:S31–S5.
   PubMed Web of Science ®Google Scholar
• Shah RR, Magdum CS, Wadkar KA, Naikwade NS. (2009). Fluconazole topical microemulsion: preparation and evaluation. Res J Pharm Tech 2:253–357.
   Google Scholar
• Spernath A, Aserin A, Ziserman L, et al. (2007). Phosphatidyl choline embedded microemulsions: physical properties and improved Caco-2 cell permeability. J Control Release 119:279–90.
   PubMed Web of Science ®Google Scholar
• Tsai YH, Lee KF, Huang YB, et al. (2010). In vitro permeation and in vivo whitening effect of topical hesperetin microemulsion delivery system. Int J Pharm 388:257–62.
   PubMed Web of Science ®Google Scholar
• Ustundag Okur N, Caglar ES, Arpa MD, Karasulu HY. (2017). Preparation and evaluation of novel microemulsion-based hydrogels for dermal delivery of benzocaine. Pharm Dev Technol 22:500–10.
   PubMed Web of Science ®Google Scholar
• Vaghani SS, Gurjar M, Singh S, et al. (2010). Effect of iontophoresis and permeation enhancers on the permeation of an acyclovir gel. Curr Drug Deliv 7:329–33.
   PubMedGoogle Scholar
• Wagner H, Kostka KH, Lehr CM, Schaefer UF. (2000). Drug distribution in human skin using two different in vitro test systems: comparison with in vivo data. Pharm Res 17:1475–81.
   PubMed Web of Science ®Google Scholar
• Wang RE, Huang YB, Wu PC, et al. (2007). The effect of iontophoresis and electroporation on transdermal delivery of indomethacin evaluated in vitro and in vivo. J Food Drug Anal 15:126–32.
   Web of Science ®Google Scholar
• Wang X, Xue M, Gu J, et al. (2012). Transdermal microemulsion drug delivery system for impairing male reproductive toxicity and enhancing efficicacy of Tripterygium Wilfordii Hook f. Fitoterapia 83:690–8.
   PubMed Web of Science ®Google Scholar
• White B, Banerjee S, O’brien S, et al. (2007). Zeta-potential measurements of surfactant-wrapped individual single-walled carbon nanotubes. J Phys Chem C 111:13684–90.
   Web of Science ®Google Scholar
• Wu H, Ramachandran C, Bielinska AU, et al. (2001). Topical transfection using plasmid DNA in a water-in-oil nanoemulsion. Int J Pharm 221:23–34.
   PubMed Web of Science ®Google Scholar
• Xi J, Chang Q, Chan CK, et al. (2009). Formulation development and bioavailability evaluation of a self-nanoemulsified drug delivery system of oleanolic acid. AAPS PharmSciTech 10:172–82.
   PubMed Web of Science ®Google Scholar
• Xie WJ, Zhang YP, Xu J, et al. (2017). The effect and mechanism of transdermal penetration enhancement of Fu’s cupping therapy: new physical penetration technology for transdermal administration with traditional Chinese medicine (TCM) characteristics. Molecules 22:525.
   Web of Science ®Google Scholar
• Xing MM, Hui X, Zhong W, et al. (2009). In vitro human topical bioactive drug transdermal absorption: estradiol. Cutan Ocul Toxicol 28:171–5.
   PubMed Web of Science ®Google Scholar
• Ye F, Miao M, Lu K, et al. (2017). Structure and physicochemical properties for modified starch-based nanoparticle from different maize varieties. Food Hydrocoll 67:37–44.
   Web of Science ®Google Scholar
• Yuan Y, Li SM, Mo FK, Zhong DF. (2006). Investigation of microemulsion system for transdermal delivery of meloxicam. Int J Pharm 321:23–117.
   Web of Science ®Google Scholar
• Zupancic M, Guilleminault C. (2006). Agomelatine: a preliminary review of a new antidepressant. CNS Drugs 20:981–92.
   PubMed Web of Science ®Google Scholar